Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: A series review

Spine

Volumn 34, Issue 14, 2009, Pages 1480-1484

  Mindea, Stefan A ^a   Shih, Patrick ^a   Song, John K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bone morphogenetic protein; Radiculitis; Transforaminal lumbar interbody fusion

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DISKOGRAPHY; FEMALE; HUMAN; INTERVERTEBRAL DISK HERNIA; MALE; MEDICAL RECORD REVIEW; MINIMALLY INVASIVE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADICULITIS; RADICULOPATHY; RETROSPECTIVE STUDY; REVIEW; SPINE FUSION; SPINE RADIOGRAPHY; SPINE SURGERY; SPONDYLOLISTHESIS;

ADULT; AGED; BONE MORPHOGENETIC PROTEINS; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; RADICULOPATHY; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPINAL FUSION; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA;

EID: 67651146552     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181a396a1     Document Type: Review

References (20)

1. Boden SD, Kang J, Sandhu H, et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 2002;27:2662-2673
2. Haid RW Jr, Branch CL Jr, Alexander JT, et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004;4:527-538
3. Boden SD, Martin GJ Jr, Horton WC, et al. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord Tech 1998;11:95-101.
4. Burkus JK, Gornet MF, Dickman CA, et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002;15:337-349 (Pubitemid 35403089)
5. Glassman SD, Carreon L, Djurasovic M, et al. Posterolateral lumbar spine with INFUSE bone graft. Spine J 2007;7:44-49 (Pubitemid 46002546)
6. Joseph V, Rampersaud YR. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis. Spine 2007;32:2885-2890 (Pubitemid 351339361)
7. Mummaneni PV, Pan J, Haid RW, et al. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 2004;1:19-23.
8. Villavicencio AT, Burneikiene, Nelson EL, et al. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J Neurosurg Spine 2005;3:436-443
9. McClellan JW, Mulconrey DS, Forbes RJ, et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006;19:483-486
10. Poynton AR, Lane JM. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 2002;27:S240-8.
11. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006;31:542-547
12. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 2006;31:2813-2819 (Pubitemid 44772783)
13. Yoon ST, Park JS, Kim KS, et al. ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine 2004;29:2603-2611
14. Burkus JK, Heim SE, Gornet MF, et al. Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Tech 2003;16:113-122 (Pubitemid 36397568)
15. Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006;31:2534-2539
16. Singh K, Smucker JD, Gill S, et al. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disord Tech 2006;19:416-423 (Pubitemid 44197593)
17. Luhmann SJ, Bridwell KH, Cheng I, et al. Use of bone morphogenetic protein- 2 for adult spinal deformity. Spine 2005;30:S110-7. (Pubitemid 41292212)
18. Potter BK, Freedman BA, Verwiebe EG, et al. Transforaminal lumbar interbody fusion: clincal and radiographic results and complications in 100 consecutive patients. J Spinal Disord Tech 2005;18:337-346
19. Hackenberg L, Halm H, Bullmann V, et al. Transforaminal lumbar interbody fusion: a safe technique with satisfactory three to five year results. Eur Spine J 2005;14:S51-8. (Pubitemid 41159462)
20. Salehi SA, Tawk R, Ganju A, et al. Transforaminal lumbar interbody fusion: surgical technique and results in 24 patients. Neurosurgery 2004;54:368-374 (Pubitemid 38209405)